iFluor® 840 Anti-human CD165 Antibody *SN2*
3204.26 EUR
In Stock
quantity
Produktdetaljer
Katalognummer: 271 - 116500Q1-500tests
Produktkategori: Företag och industri > Vetenskap och laboratorium
Gentaur
Storlek: 500 tests
Parameters
| Storage and shipping | See Protocol |
|---|
116500Q0-100tests
iFluor® 840 Anti-human CD165 Antibody *SN2*
The SN2 monoclonal antibody recognizes human CD165, a glycoprotein typically expressed on the surface of monocytes, fibroblasts, T cells and thymocytes.
948.26 €
116500Q1-500tests
iFluor® 840 Anti-human CD165 Antibody *SN2*
The SN2 monoclonal antibody recognizes human CD165, a glycoprotein typically expressed on the surface of monocytes, fibroblasts, T cells and thymocytes.
3204.26 €
116500Q0
iFluor® 840 Anti-human CD165 Antibody *SN2*
The SN2 monoclonal antibody recognizes human CD165, a glycoprotein typically expressed on the surface of monocytes, fibroblasts, T cells and thymocytes.
964.76 €
116500R1-500tests
iFluor® 860 Anti-human CD165 Antibody *SN2*
The SN2 monoclonal antibody recognizes human CD165, a glycoprotein typically expressed on the surface of monocytes, fibroblasts, T cells and thymocytes.
3204.26 €
116501P0-25tests
PE/iFluor® 647 Anti-human CD165 Antibody *SN2*
The SN2 monoclonal antibody recognizes human CD165, a glycoprotein typically expressed on the surface of monocytes, fibroblasts, T cells and thymocytes.
771.26 €
116501P1-100tests
PE/iFluor® 647 Anti-human CD165 Antibody *SN2*
The SN2 monoclonal antibody recognizes human CD165, a glycoprotein typically expressed on the surface of monocytes, fibroblasts, T cells and thymocytes.
1803.26 €
Håll dig uppdaterad! Visa tidigare publikationer
By: Author , 2 Comment
Anaplasmos hos hundar och katter – allt du behöver veta
23 August 2025
By: Author , 2 Comment
Solbränna – hur leker man säkert i solen?
16 August 2025
By: Author , 2 Comment
Biologiska läkemedel – Modernitet inom farmaci
1 August 2025
By: Author , 2 Comment
Icke-steroida antiinflammatoriska läkemedel – viktig information om populära läkemedel
22 July 2025